Photo by nci from unsplash
Ischaemic heart failure (IHF) patients have a poor prognosis even with current guideline‐derived therapy. Intramyocardial injections of autologous or allogeneic mesenchymal stromal cells might improve cardiac function leading to better… Click to show full abstract
Ischaemic heart failure (IHF) patients have a poor prognosis even with current guideline‐derived therapy. Intramyocardial injections of autologous or allogeneic mesenchymal stromal cells might improve cardiac function leading to better clinical outcome.
Keywords:
european multicentre;
design european;
study stem;
multicentre study;
stem cell;
rationale design
Journal Title: European Journal of Heart Failure
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: European Journal of Heart Failure
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!